Improving PTSD Treatment Outcomes with Motivation and Shared Decision-Making for Adults with PTSD at Two Specialized Clinics

What this Trial Is About

Researchers are evaluating ways to improve outpatient treatment for posttraumatic stress disorder PTSD at two clinics serving mainly ethnic Danes and refugees. This study includes two randomized controlled trials to examine whether adding a motivation enhancement module before treatment reduces dropout and improves outcomes, and whether adding a Shared Decision-Making session to tailor treatment leads to better results. The study also explores cognitive differences between these groups, the role of motivation, and patient and clinician views on these interventions. Participants receive one of several behavioral treatment approaches. One group receives treatment as usual TAU lasting 8 to 12 months. Another group receives an introductory PTSD module of four motivation-focused sessions before continuing with TAU, lasting 9 to 13 months. At one clinic, an additional group also receives the motivation module plus a Shared Decision-Making session to choose among four standardized treatments before continuing individualized care. Treatments involve sessions with psychologists, nurses, and medical doctors. Participants undergo initial assessments including clinical interviews and diagnostic tools, followed by randomization into study groups. Throughout treatment, patients complete self-ratings and observer-rated scales at multiple points including follow-up six months after treatment ends. Researchers collect detailed data on attendance, session content, symptom severity, cognitive function, and treatment engagement. The primary outcome is change in PTSD symptoms measured by the International Trauma Questionnaire after about 10 months. Secondary outcomes include measures of depression, functioning, well-being, and patient satisfaction.

Patient Engagement in PTSD Treatment (PEP)